The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

ConditionsSarcopenia in Elderly Malnourished Protein Supplementation Muscle Mass Physical Function Strength

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age60+

SponsorNuritas Ltd

About this trial

Examining the effects of MediDrink Platinum+ containing novel protein blend SRP-01 alone or when combined with PeptiStrong on clinical responses in elderly adults with sarcopenia

Eligibility criteria

Qualifiers

60 years or older

BMI ≤ 25 kg/m²

Malnourished (mini nutritional assessment MNA <11

Sarcopenic: SARC-F score ≥ 4

Disqualifiers

Patient cannot eat orally

Acute Infection

Proven Intestinal obstruction

Co-morbidities requiring a special diet (diabetes, kidney disease etc.)

Trial design

Treatments tested in this trial

MediDrink Platinum+
MediDrink Platinum+ and PeptiStrong

Treatment groups

75 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Nuritas Ltd

Lead sponsor

Medifood Hungary Innovation Kft

Collaborator

Source ClinicalTrials.gov